Venus Concept Inc (VERO): Market Cap to Revenue
Venus Concept Inc. (VERO) develops advanced non-invasive rejuvenation systems, making aesthetic correction accessible. Business restructuring and the sale of consumables in the US drive growth. The brand is recognized as a reliable global supplier of high-quality equipment. The current price-to-sales ratio helps assess market balance, while 0.00 reflects the latest metric level on this chart.
Analytical breakdowns for Venus Concept Corp (VERO)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- book value of equity indicators:
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Venus Concept Inc.|VERO - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Venus Concept Corporation|VERO - Company Aggregate Debts|Debts to Book Capitalization Venus Concept Corp|VERO - Company Long-Term Debt|Company Short-Term Debt Venus Concept|Intermediate Coverage Ratio venusconcept.com
- earnings and multiples data:
VERO - Net Profit|Expected Net Profit Venus Concept Inc.|VERO - Price to Earnings Ratio|Forward Price to Earnings Multiple Venus Concept Inc|VERO - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Venus Concept Corp|VERO - Operating profit EBITDA|Net earnings per share for the last four quarters Venus Concept|VERO - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months venusconcept.com|VERO - Earnings per share growth in current year|Expected earnings per share growth for next year Venus Concept Inc.
- issuer revenue and sales details:
General company analysis:VERO venusconcept.com
The efficiency of Venus Concept Inc. (VERO) Canadian production facilities for aesthetic equipment is reflected in the price-to-sales ratio, which compares market capitalization to annual revenue. This metric, calculated by dividing the total equity value by revenue, allows investors to assess the degree of overpayment for the business and the risk of correction at inflated values or the asset's undervaluation.
Competitors of Venus Concept Inc.
DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Intelligent Bio Solutions - Market Cap to Sales Volume|XAIR (beyondair.net) - Market Cap to Revenue|PFSA (profusa.com) - Price-to-Revenue Ratio|SSKN (STRATA Skin Sciences Inc.) - P/S Multiple|Price to Sales glucotrack.com GCTK|Price-to-Revenue Ratio NanoVibronix (NAOV)|Nuwellis Corp - Market Cap to Revenue Ratio|Aethlon Medical - Market Cap to Revenue|P/S Multiple Asensus Surgical Inc ASXC|AVGR - Price-to-Revenue Ratio|Price-to-Revenue Coefficient BioSig BSGM|CUTR (Cutera, Inc) - Market Cap to Revenue|Know Labs Corporation - Market Capitalization-to-Revenue Ratio|NARI (Inari Medical, Inc.) - P/S Multiple|Market Cap to Revenue nevro.com (NVRO)|Price-to-Revenue Ratio ReShape Lifesciences (RSLS)|SILK - Price to Sales
